Middle East & Africa Mid-Size Pharmaceutical Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Prescription and Over-the-Counter), Drug Development Type (In-House and Outsource), Formulation (Tablets and Capsules, Injectables, Sprays, and Other Formulations), and Therapy Class (Cardiovascular Diseases, Pain Management, Diabetes, Cancer, and Other Conditions)      

Code: BMIRE00026184 | Pages: 128 | Industry: Pharmaceuticals | Date: Sep 2022 | Type: Regional

The mid-size pharmaceutical market in the Middle East & Africa is expected to grow from US$ 19,569.41 million in 2022 to US$ 23,913.96 million by 2028; it is estimated to grow at a CAGR of 3.4% from 2022 to 2028.

 

Pharmaceutical companies are interested in ensuring R&D achieves their intended goal. The number of new drugs approved each year has also increased over the last decade. Efforts are being made to achieve greater effectiveness and efficiency in meeting patients' needs. Recent studies have estimated average R&D costs per new drug are less than US$ 1 billion to over US$ 2 billion per drug. These estimates include the cost of laboratory and clinical trials of successful new drugs and drugs that enter clinical trials but fail or do not go through the laboratory development phase. These top trends transform the pharmaceutical industry and can have short-term and long-term implications. Therefore, the surging focus on R&D drives the growth of the Middle East & Africa mid-size pharmaceutical market.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Middle East & Africa mid-size pharmaceutical market. The Middle East & Africa mid-size pharmaceutical market is expected to grow at a good CAGR during the forecast period.

 

 Middle East & Africa Mid-Size Pharmaceutical Market Revenue and Forecast to 2028 (US$ Million)

 Middle East & Africa Mid-Size Pharmaceutical Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :

 

 

 

Middle East & Africa Mid-Size Pharmaceutical Market Segmentation

 

The Middle East & Africa mid-size pharmaceutical market is segmented on the basis of type, drug development type, formulation, therapy class, and country.

 

Based on type, the Middle East & Africa mid-size pharmaceutical market is bifurcated into prescription and over-the-counter. In 2022, the over-the-counter segment accounted for a larger market share. Based on drug development type, the market is bifurcated into in-house and outsource. The outsource segment held a larger market share in 2022. Based on formulation, the Middle east & Africa mid-size pharmaceutical market is segmented into tablets and capsules, injectables, sprays, and other formulations. The tablets & capsules segment held the largest market share in 2022. Based on therapy class, the market is segmented into cardiovascular diseases, pain management, diabetes, cancer, and other conditions. The diabetes segment held the largest market share in 2022. Based on country, the Middle East & Africa mid-size pharmaceutical market is segmented into Saudi Arabia, South Africa, the UAE, and Rest of Middle East & Africa. Saudi Arabia held the largest market share in 2022.

 

Alexion Pharmaceuticals, Inc.; Bausch Health Companies Inc.; Daiichi Sankyo Company Limited; Endo Pharmaceuticals Inc.; Mallinckrodt; and Sun Pharmaceutical Industries Ltd are among the leading companies operating in the mid-size pharmaceutical market in the region.

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        MEA Mid-Size Pharmaceutical – By Type

1.3.2        MEA Mid-Size Pharmaceutical – By Drug Development Type

1.3.3        MEA Mid-Size Pharmaceutical – By Formulation

1.3.4        MEA Mid-Size Pharmaceutical – By Therapy Area

1.3.5        MEA Mid-Size Pharmaceutical – By Country

2.           Mid-Size Pharmaceutical– Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           MEA Mid-Size Pharmaceutical – Market Landscape

4.1         Overview

4.2         MEA PEST Analysis

4.3         Expert Opinion

5.           Mid-Size Pharmaceutical Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Cases of Chronic Disorders

5.1.2        New Product Approval and Launches

5.2         Market Restraints

5.2.1        High Competition Among Market Players

5.3         Market Opportunities

5.3.1        Rising Number of Healthcare Start-ups

5.4         Future Trends

5.4.1        Surging Focus on R&D

5.5         Impact Analysis

6.           Mid-Size Pharmaceutical Market– MEA Analysis

6.1         MEA Mid-Size Pharmaceutical Market Revenue Forecast And Analysis

7.           MEA Mid-Size Pharmaceutical Market Revenue and Forecasts To 2028– by Type

7.1         Overview

7.2         MEA Mid-Size Pharmaceutical Market Revenue Share, by Type (2022 and 2028)

7.3         Prescription

7.3.1        Overview

7.3.2        Prescription: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Over-the-Counter (OTC)

7.4.1        Overview

7.4.2        Over-the-Counter: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

8.           MEA Mid-Size Pharmaceutical Market Analysis – By Drug Development Type

8.1         Overview

8.2         MEA Mid-Size Pharmaceutical Market Revenue Share, by Drug Development Type (2022 and 2028)

8.3         In-House

8.3.1        Overview

8.3.2        In-House: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Outsource

8.4.1        Overview

8.4.2        Outsource: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

9.           MEA Mid-Size Pharmaceutical Market – By Formulation

9.1         Overview

9.2         MEA Mid-Size Pharmaceutical Market, by Formulation, 2022 and 2028 (%)

9.3         Tablets and Capsules

9.3.1        Overview

9.3.2        Tablets and Capsules: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Injectables

9.4.1        Overview

9.4.2        Injectables: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Sprays

9.5.1        Overview

9.5.2        Sprays: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

9.6         Other Formulations

9.6.1        Overview

9.6.2        Others: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

10.        MEA Mid-Size Pharmaceutical Market – By Therapy Class

10.1      Overview

10.2      MEA Mid-Size Pharmaceutical Market, by Therapy Class, 2022 and 2028 (%)

10.3      Cardiovascular Diseases

10.3.1     Overview

10.3.2     Cardiovascular Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

10.4      Pain Management

10.4.1     Overview

10.4.2     Pain Management: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

10.5      Diabetes

10.5.1     Overview

10.5.2     Diabetes: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

10.6      Cancer

10.6.1     Overview

10.6.2     Cancer: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

10.7      Other Diseases

10.7.1     Overview

10.7.2     Other Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

11.        MEA Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 – Country Analysis

11.1      Overview

11.1.1     MEA Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Country (%)

11.1.1.1       UAE: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.1.1       Overview

11.1.1.1.2       UAE: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.1.3       UAE: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million)

11.1.1.1.4       UAE: Mid-Size Pharmaceutical Market Revenue and Forecasts To 2028, By Drug Development Type (US$ Million)

11.1.1.1.5       UAE: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.6       UAE: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2       Saudi Arabia: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.2.1       Overview

11.1.1.2.2       Saudi Arabia: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.2.3       Saudi Arabia: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million)

11.1.1.2.4       Saudi Arabia: Mid-Size Pharmaceutical Market Revenue and Forecasts To 2028, By Drug Development Type (US$ Million)

11.1.1.2.5       Saudi Arabia: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.6       Saudi Arabia: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3       South Africa: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.3.1       Overview

11.1.1.3.2       South Africa Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.3.3       South Africa: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million)

11.1.1.3.4       South Africa: Metabolomics Market Revenue and Forecasts To 2028, By Drug Development Type (US$ Million)

11.1.1.3.5       South Africa: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.6       South Africa: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)

11.1.1.4       Rest of MEA: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.4.1       Overview

11.1.1.4.2       Rest of MEA: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.4.3       Rest of MEA: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million)

11.1.1.4.4       Rest of MEA: Metabolomics Market Revenue and Forecasts To 2028, By Drug Development Type (US$ Million)

11.1.1.4.5       Rest of MEA: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)

11.1.1.4.6       Rest of MEA: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)

12.        Mid-Size Pharmaceutical Market–Industry Landscape

12.1      Overview

12.2      Growth Strategies Done by the Companies in the Market, (%)

12.3      Organic Developments

12.3.1     Overview

12.4      Inorganic Developments

12.4.1     Overview

13.        Company Profiles

13.1      DAIICHI SANKYO COMPANY LIMITED

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Bausch Health Companies Inc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Sun Pharmaceutical Industries Ltd

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Alexion Pharmaceuticals, Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Mallinckrodt

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Endo Pharmaceuticals Inc.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

 

 

LIST OF TABLES

Table 1.             UAE: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million)

Table 2.             UAE: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Drug Development Type (US$ Million)

Table 3.             UAE: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)

Table 4.             UAE: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)

Table 5.             Saudi Arabia: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million)

Table 6.             Saudi Arabia: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Drug Development Type (US$ Million)

Table 7.             Saudi Arabia: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Saudi Arabia: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)

Table 9.             South Africa Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million)

Table 10.          South Africa: Metabolomics Market Revenue and Forecasts to 2028, By Drug Development Type (US$ Million)

Table 11.          South Africa: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)

Table 12.          South Africa: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Rest of MEA: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Type (US$ Million)

Table 14.          Rest of MEA: Metabolomics Market Revenue and Forecasts to 2028, By Drug Development Type (US$ Million)

Table 15.          Rest of MEA: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)

Table 16.          Rest of MEA: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)

Table 17.          Organic Developments Done By Companies

Table 18.          Inorganic Developments Done By Companies

Table 19.          Glossary of Terms

 

LIST OF FIGURES

Figure 1.           MEA Mid-Size Pharmaceutical Segmentation

Figure 2.           MEA Mid-Size Pharmaceutical Segmentation, By Country

Figure 3.           MEA Mid-Size Pharmaceutical Overview

Figure 4.           Over-the-Counter Segment Held Largest Share by Type in MEA Mid-Size Pharmaceutical Market

Figure 5.           Saudi Arabia is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Middle East & Africa: PEST Analysis

Figure 7.           MEA Mid-Size Pharmaceutical Market– Revenue Forecast And Analysis – 2020- 2028

Figure 8.           MEA Mid-Size Pharmaceutical Market Revenue Share, by Type (2022 and 2028)

Figure 9.           MEA Prescription: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10.        MEA Over-the-Counter: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        MEA Mid-Size Pharmaceutical Market Revenue Share, by Drug Development Type (2022 and 2028)

Figure 12.        MEA In-House: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        MEA Outsource: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        MEA Mid-Size Pharmaceutical Market, by Formulation, 2022 and 2028 (%)

Figure 15.        MEA Tablets and Capsules: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        MEA Injectables: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        MEA Sprays: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        MEA Others: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        MEA Mid-Size Pharmaceutical Market, by Therapy Class, 2022 and 2028 (%)

Figure 20.        MEA Cardiovascular Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        MEA Pain Management: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        MEA Diabetes: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        MEA Cancer: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        MEA Other Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        MEA Mid-Size Pharmaceutical Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 26.        MEA Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028, By Country (%)

Figure 27.        UAE: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28.        Saudi Arabia: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)

Figure 29.        South Africa: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)

Figure 30.        Rest of MEA: Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 (US$ Million)

Figure 31.        Growth Strategies Done by the Companies in the Market, (%)

 

  1. Alexion Pharmaceuticals, Inc.
  2. Bausch Health Companies Inc.
  3. Daiichi Sankyo Company Limited
  4. Endo Pharmaceuticals Inc.
  5. Mallinckrodt
  6. ssSun Pharmaceutical Industries Ltd
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000